Financial technology specialist ION has capped off a tremendous period of growth, with a record £1.3M contract win.
Following a strong 12 months for Newcastle based ION, the business has secured a three-year contract with Quotient Sciences, a global drug development and manufacturing accelerator. The project will focus on transforming Quotient’s CRM and Financial technology stack, to create a unified cloud platform that will support the company in its growth journey.
Quotient Sciences provides integrated and tailored drug substance, drug product, and clinical testing services that span the entire drug development pathway. Having all these services under one organisation allows them to save their customers precious time and money in getting new medicines to patients faster. Headquartered in Nottingham, Quotient Sciences currently has over 1,200 employees across 7 locations in the UK and US.
As a specialist in lead-to-ledger technologies, ION works with mid-market businesses to deploy advanced accounting, billing, and CRM cloud applications. Having previously worked with Alnwick-based Arcinova, ION was selected as the technology partner of choice when the organisation was acquired by Quotient Sciences earlier this year.
Managing Director, Rob Mathieson said: “ION is delighted to be partnering with Quotient Sciences to deliver this transformative project. Their industry-leading solution will bring all company activities and intelligence into one platform, improving efficiency and driving growth across their business.”
This new project award comes off the back of a strong period of growth for ION which has seen the team expand to 42 employees over the last 12 months.
“The demand for skills is so high right now and that’s why we are proud to have such a talented and dedicated team. We don’t take this for granted and have focused our energies on ensuring we can attract and retain the best people. This also includes expanding our ION Academy Programme to help get more young people into tech careers.
The Quotient project will involve utilising all these great skills across our business. As a team we are very excited and can’t wait to deliver a great result for Quotient Sciences.”
ION is currently recruiting for Academy and Professional roles across the business, visit www.ionhq.co.uk/careers for more information.
About ION: ION helps businesses thrive in the digital world, creating unified cloud platforms to transform business and financial processes. Partnering with some of the world’s leading cloud accounting and CRM technologies, the ION team collaborates with mid-market businesses to provide cloud solutions that support their growth journey.
About Quotient Sciences: Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, and molecules need to become cures, fast. Because humanity needs solutions, fast.
For further information about this story or ION, please contact Terry Stephenson, Marketing Manager at ION terry.stephenson@ionhq.co.uk, Tel: 0191 466 1231
